SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-000361
Filing Date
2023-01-06
Accepted
2023-01-06 17:28:14
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 athira_424b5.htm 424B5 1205102
2 GRAPHIC img40584813_0.jpg GRAPHIC 21008
3 GRAPHIC img40584813_1.jpg GRAPHIC 6410
4 GRAPHIC img40584813_2.jpg GRAPHIC 27644
5 GRAPHIC img40584813_3.jpg GRAPHIC 155530
6 GRAPHIC img40584813_4.jpg GRAPHIC 21008
7 GRAPHIC img40584813_5.jpg GRAPHIC 142347
8 GRAPHIC img40584813_6.jpg GRAPHIC 21008
9 GRAPHIC img40584813_7.jpg GRAPHIC 6470
10 GRAPHIC img40584813_8.jpg GRAPHIC 27644
  Complete submission text file 0000950170-23-000361.txt   1787264
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261073 | Film No.: 23516033
SIC: 2836 Biological Products, (No Diagnostic Substances)